In vitro models for the study of the effect of butyrate on human colon adenocarcinoma cells

Toxicology in Vitro

Volumn 21, Issue 2, 2007, Pages 262-270

  Olmo, N ^a   Turnay, J ^a   Perez Ramos P ^a   Lecona, E ^a   Barrasa, J I ^a   Lopez de Silanes I ^a   Lizarbe, M A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Apoptosis; Butyrate; Colon adenocarcinoma; Differentiation; Multicellular spheroids

Indexed keywords

ALKALINE PHOSPHATASE; BUTYRIC ACID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CANCER RESISTANCE; CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONOPHARMACOLOGY; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTICELLULAR SPHEROID; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; UPREGULATION;

ADENOCARCINOMA; ALKALINE PHOSPHATASE; APOPTOSIS; BUTYRATES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; SPHEROIDS, CELLULAR;

EID: 33846849239     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.09.011     Document Type: Article

References (21)

1. Dashwood R.H., Myzak M.C., and Ho E. Dietary HDAC inhibitors: time to rethink weak ligands in cancer chemoprevention?. Carcinogenesis 27 (2006) 344-349
2. Della Ragione F., Criniti V., Della Pietra V., Borriello A., Oliva A., Indaco S., Yamamoto T., and Zappia V. Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Letters 499 (2001) 199-204
3. Ferrante A., Rainaldi G., Indovina P., Indovina P.L., and Santini M.T. Increased cell compaction can augment the resistance of HT-29 human colon adenocarcinoma spheroids to ionizing radiation. International Journal of Oncology 28 (2006) 111-118
4. Gibson P.R. Apoptosis or necrosis-colonic epithelial cell survival. Novartis Foundation Symposium 263 (2004) 133-145
5. Grantab R., Sivananthan S., and Tannock I.F. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Research 15 (2006) 1033-1039
6. Guzmán-Aránguez A., Olmo N., Turnay J., Lecona E., Pérez-Ramos P., López de Silanes I., and Lizarbe M.A. Differentiation of human colon adenocarcinoma cells alters the expression and intracellular localization of annexins A1, A2, and A5. Journal of Cellular Biochemistry 94 (2005) 178-193
7. Khaitan D.D., Chandna S.S., Arya M.B., and Dwarakanath B.S. Establishment and characterization of multicellular spheroids from a human glioma cell line: implications for tumor therapy. Journal of Translational Medicine 4 (2006) 12
8. Kouraklis G., and Theocharis S. Histone deacetylase inhibitors: a novel target of anticancer therapy. Oncology Reports 15 (2006) 489-494
9. López-Conejo T., Olmo N., Turnay J., Navarro J., and Lizarbe M.A. Characterization of tumorigenic sub-lines from a poorly tumorigenic human colon-adenocarcinoma cell line. International Journal of Cancer 67 (1996) 668-675
10. López de Silanes I., Olmo N., Turnay J., González de Buitrago G., Pérez-Ramos P., Guzmán-Aránguez A., Garci{dotless}́a-Diez M., Lecona E., Gorospe M., and Lizarbe M.A. Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon adenocarcinoma cells. Cancer Research 64 (2004) 4593-4600
11. Marshall J.L., and Hwang J. The impact of targeted therapy on the treatment of colorectal cancer. Oncology (Williston Park) 19 (2005) 19-24
12. Miller S.J. Cellular and physiological effects of short-chain fatty acids. Mini-Reviews in Medicinal Chemistry 4 (2004) 839-845
13. Navarro J.M., Olmo N., Turnay J., López-Conejo M.T., and Lizarbe M.A. Differentiation of BCS-TC2 human colon adenocarcinoma cells by sodium butyrate: increase of 5'-nucleotidase activity. European Journal of Clinical Investigation 27 (1997) 620-628
14. Pérez-Ramos P., Olmo N., Turnay J., Lecona E., González de Buitrago G., Portolés M.T., and Lizarbe M.A. Effect of bile acids on butyrate sensitive and resistant human colon adenocarcinoma cells. Nutrition and Cancer 52 (2005) 208-219
15. Raju R., and Cruz-Correa M. Chemoprevention of colorectal cancer. Diseases of the Colon and Rectum 49 (2006) 113-124
16. Rupnarain C., Dlamini Z., Naicker S., and Bhoola K. Colon cancer: genomics and apoptotic events. Biological Chemistry 385 (2004) 449-464
17. Schroy P., Rustgi A.K., Ikonomu E., Liu X.P., Polito J., Andry C., and O'Keanne J.C. Growth and intestinal differentiation are independently regulated in HT-29 colon cancer cells. Journal of Cellular Physiology 161 (1994) 111-123
18. Tabuchi Y., Arai Y., Kondo T., Takeguchi N., and Asano S. Identification of genes responsive to sodium butyrate in colon epithelial cells. Biochemical and Biophysical Research Communications 293 (2002) 1287-1294
19. Tian J.Q., and Quaroni A. Dissociation between growth arrest and differentiation in Caco-2 subclone expressing high levels of sucrase. America Journal of Physiology-Gastrointestinal and Liver Physiology 276 (1999) 1094-1104
20. Turnay J., Olmo N., Gavilanes J.G., Beni{dotless}́tez J., and Lizarbe M.A. Establishment and characterization of a new human colon-adenocarcinoma cell line: BCS-TC2. Cytotechnology 3 (1990) 75-88
21. Young G.P., Hu Y., Le Leu R.K., and Nyskohus L. Dietary fibre and colorectal cancer: a model for environment-gene interactions. Molecular Nutrition and Food Research 49 (2005) 571-584